567-06-008 ISMRM Abstract

Assessing the Role of DCE-MRI in Enhancing the Positive Predictive Value of PI-RADS 3 Lesions for Prostate Cancer

Primary: Body - Prostate

Secondary: Contrast Mechanisms - Perfusion

567-06-008 · Novel Contrast Mechanisms II · Wednesday, 13 May, 4:55 PM–5:50 PM · Digital Posters Row H

Keywords: Prostate MRI DCE-MRI PI-RADS 3 lesions Positive predictive value Prostate Cancer Detection

Accepted

Nader Gharbia ¹, Yasmine Saad², Kaies Chaker³, Aymen Kammoun⁴, Wasim Frikha³, Yassine Nouira³

¹Faculty of medicine of Sfax, Tunisia

²Faculty of Medicine of Monastir, Tunisia

³Faculty of medicine of Tunis, Tunisia

⁴Faculty of Sciences of Monastir, Tunisia

Presenting Author: Nader Gharbia

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Mazaheri Y, Akin O, Hricak H. Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications. World J Radiol. 2017 Dec 28;9(12):416-425. doi: 10.4329/wjr.v9.i12.416. [doi]

2. Parra NA, Pollack A, Chinea FM, Abramowitz MC, Marples B, Munera F, Castillo R, Kryvenko ON, Punnen S, Stoyanova R. Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness. Front Oncol. 2017 Nov 10;7:259. doi: 10.3389/fonc.2017.00259. [doi]

3. Drevik J, Dalimov Z, Uzzo R, Danella J, Guzzo T, Belkoff L, Raman J, Tomaszewski J, Trabulsi E, Reese A, Singer EA, Syed K, Jacobs B, Correa A, Smaldone M, Ginzburg S. Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative. Urol Oncol. 2022 Nov;40(11):490.e1-490.e6. doi: 10.1016/j.urolonc.2022.08.003. [doi]

4. Prabhu V, Rosenkrantz AB, Otazo R, Sodickson DK, Kang SK. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis. J Magn Reson Imaging. 2019 May;49(5):1400-1408. doi: 10.1002/jmri.26318. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/567-06-008